A proven roadmap for innovation and commercialization
We empower inventors — paving pathways, clearing obstacles and dedicating significant resources to technology transfer.
Impact Dashboard
* One hundred percent of startups launched with investor funding or were revenue generating.
This is WashU Innovation
The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.
Explore our innovation community
Upcoming Events
NEURO360
Introducing NEURO360 – Advancing Neuroscience Technologies to improve cognitive wellness
Needlemans commit $15 million to boost drug discovery
A generous gift from longtime benefactors of Washington University School of Medicine in St. Louis establishes the Needleman Program for Innovation and Commercialization. For a select number of projects, the new program will provide funding to help move promising therapeutics towards the stage where the Food and Drug Administration grants investigational new drug (IND) status.
In the news
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway
Levy appointed executive vice chancellor for medical affairs, dean of WashU Medicine
Bruce D. Levy, MD, is an accomplished physician-scientist and a highly regarded leader in academic medicine
WashU’s economic impact totals $9.8 billion
University drew $1 billion in external funding that led to scientific advances, new jobs
Announcements
Mitra receives innovation award
Five named National Academy of Inventors senior members
Lanza named fellow of National Academy of Inventors
Resources for Students & Alumni
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.